Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Hull

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current HIV/AIDS Reports|March 30, 2011
Antiretroviral therapy: a key component of a comprehensive HIV prevention strategyMark W Hull, Julio Montaner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2025
Responsible use of doxycycline for STI prevention includes both recognizing its benefits and planning for antimicrobial resistance monitoringTroy Grennan, Mark W Hull
Infectious Disease Clinics of North America|June 15, 2007
Indigenous microflora and innate immunity of the head and neckMark W Hull, Anthony W Chow
Canadian Family Physician Medecin De Famille Canadien|December 16, 2004
Clostridium difficile-associated colitisMark W Hull, Paul L Beck
Current Infectious Disease Reports|December 22, 2004
An Approach to Oral Infections and Their ManagementMark W Hull, Anthony W Chow
The Journal of Infectious Diseases|September 16, 2011
Optimizing initial therapy for HIV infectionMark W Hull, Julio S G Montaner
Expert Opinion on Pharmacotherapy|April 7, 2010
Etravirine in combination with darunavir/ritonavir and optimized background regimen results in suppression of HIV replication in treatment-experienced patients. Evaluation of Katlama C, Haubrich R, Lalezari J, et al. Efficacy and safety of etravirine in treatment-experienced HIV-1 patients: pooled 48-week analysis of two randomized, controlled trials. AIDS 2009; 23: 2289-300Mark W Hull, Julio S G Montaner
Annals of Medicine|April 20, 2011
Ritonavir-boosted protease inhibitors in HIV therapyMark W Hull, Julio S G Montaner
Journal of Food and Drug Analysis|September 13, 2014
HIV treatment as prevention: the key to an AIDS-free generationMark W Hull, Julio S G Montaner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2012
Reply to Mandorfer et alMark W Hull, Kathleen Rollet, Marina B Klein, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current HIV/AIDS Reports|March 30, 2011
Antiretroviral therapy: a key component of a comprehensive HIV prevention strategyMark W Hull, Julio Montaner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2025
Responsible use of doxycycline for STI prevention includes both recognizing its benefits and planning for antimicrobial resistance monitoringTroy Grennan, Mark W Hull
Infectious Disease Clinics of North America|June 15, 2007
Indigenous microflora and innate immunity of the head and neckMark W Hull, Anthony W Chow
Canadian Family Physician Medecin De Famille Canadien|December 16, 2004
Clostridium difficile-associated colitisMark W Hull, Paul L Beck
Current Infectious Disease Reports|December 22, 2004
An Approach to Oral Infections and Their ManagementMark W Hull, Anthony W Chow
The Journal of Infectious Diseases|September 16, 2011
Optimizing initial therapy for HIV infectionMark W Hull, Julio S G Montaner
Expert Opinion on Pharmacotherapy|April 7, 2010
Etravirine in combination with darunavir/ritonavir and optimized background regimen results in suppression of HIV replication in treatment-experienced patients. Evaluation of Katlama C, Haubrich R, Lalezari J, et al. Efficacy and safety of etravirine in treatment-experienced HIV-1 patients: pooled 48-week analysis of two randomized, controlled trials. AIDS 2009; 23: 2289-300Mark W Hull, Julio S G Montaner
Annals of Medicine|April 20, 2011
Ritonavir-boosted protease inhibitors in HIV therapyMark W Hull, Julio S G Montaner
Journal of Food and Drug Analysis|September 13, 2014
HIV treatment as prevention: the key to an AIDS-free generationMark W Hull, Julio S G Montaner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2012
Reply to Mandorfer et alMark W Hull, Kathleen Rollet, Marina B Klein, et al.
Pageof 6